Physician
General Surgery
Dr. Philip B. Seu, MD
|
|
Give Review
Philip works in the field of General Surgery. Philip B. Seu is a published MD. He published 57 publications, including: 'Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma.
- Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis.
- Deregulation of iron homeostasis and cold-preservation injury to rat liver stored in University of Wisconsin solution.
- Disruption of the Nramp1 (also known as Slc11a1) gene in Kupffer cells attenuates early-phase, warm ischemia-reperfusion injury in the mouse liver.
- Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient.
- Tyrosinemia.
- Maintenance of the celiac trunk with the left-sided liver allograft for in situ split-liver transplantation.
- The natural resistance-associated macrophage protein 1 Slc11a1 (formerly Nramp1) and iron metabolism in macrophages.
- Ischemia-reperfusion of rat liver modulates hepcidin in vivo expression.
- Current and future treatment modalities for hepatocellular carcinoma.
- Management of complicated pneumatocele.
- In situ splitting of the cadaveric liver for two adult recipients.
- Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression.
- A simple model to estimate survival after retransplantation of the liver.
- Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir.
- Experience with combined liver-small intestine transplantation at the University of California, Los Angeles.
- Long-term results of pediatric liver transplantation: an analysis of 569 transplants.
- The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.
- Legionella pneumonia in liver transplant recipients.
- Liver transplantation for fulminant hepatic failure in the pediatric patient.
- Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
- Liver transplantation for adult polycystic liver disease.
- Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
- One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
- Liver transplantation for decompensated cirrhosis after jejunoileal bypass: a strategy for management.
- Fas ligand gene transfer to renal allografts in rats: effects on allograft survival.
- Effects of pravastatin on chronic rejection of rat cardiac allografts.
- In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.
- Significance of early aminotransferase elevation after liver transplantation.
- Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seroposit...
- Long-term survival after retransplantation of the liver.
- Aplastic anemia complicating orthotopic liver transplantation.
- In situ splitting of the cadaveric liver for transplantation.
- Pravastatin increases survival and inhibits natural killer cell enhancement factor in liver transplanted rats.
- Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
- The impact of microsurgical hepatic arterial reconstruction on the outcome of liver transplantation for congenital biliary atresia.
- Lower extremity paralysis after use of the supraceliac aorta for hepatic arterial reconstruction of the transplanted liver.
- Liver transplantation for fulminant hepatic failure in a Jehovah''s Witness.
- Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
- Orthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experience.
- Improved results of liver transplantation in patients with portal vein thrombosis.
- A prospective study on the reliability and cost effectiveness of preoperative ultrasound screening of the "marginal" liver donor.
- The role of whole organ pancreas transplantation in the treatment of type I diabetes.
- Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated p...
- Anti-tumor necrosis factor antibody enhances allograft survival in rats.
- The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allog...
- Monoclonal anti-tumor necrosis factor-alpha antibody treatment of rat cardiac allografts: synergism with low-dose cyclosporine and immunohistological studies.
- Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody.
- Effects of tumor necrosis factor (TNF) and immunotherapy directed against TNF on rat cardiac transplants.
- Ultrastructural and immunohistologic study of Kupffer cells in orthotopic transplanted rat liver.
- The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.
- Liver transplantation at UCLA: report of clinical activities.
- The hepatorenal syndrome in liver transplant recipients.
- PGE1 reduces injury in hepatic allografts following preservation.
- Interleukin-6 in bile as a marker of allograft rejection following liver transplantation in man.
- Liver resection for primary neoplasms.
Schools
University of Texas At Galveston Medical Branch
Procedures Preformed
- Varicose Vein Procedure
Conditions Treated
- Varicose Veins
Doctors Specialties
- General Surgery
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Choice Health PPO
- GEHA
- Medicare Advantage PFFS
- Humana
- Medicaid
- Medicare MCR
- MultiPlan PPO
- Old Surety Life Insurance CompanyMedicare MCR
- Heritage Signature
- Thrivent Financial
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Education
-
UCLA Medical Center -
University of Texas Medical Branch
Drug Facts
| NPI NUMBER | 1316969405 | |
| NPPES Provider LastName | SEU | |
| NPPES Provider FirstName | PHILIP | |
| NPPES Provider ZIPCode | 591028624 | |
| NPPES Provider State | MT | |
| Specialty Description | General Surgery | |
| Total Claim Count | 25.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316969405 |
| Last Name Of The Provider | SEU |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
|
Dr. Charles G. Welch, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William S. Evans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathaniel Rieb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Johnson II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas H. Etter, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Linda S. Byrd, RT |